Dawn Halkuff Email & Phone Number

Florida, United States

Greater Chicago Area

Company: $110 million provider of commercial therapeutic products and a unique injection technology platform.Chair: Nominating/Governance Committee Member: Compensation Committee

Miami-Fort Lauderdale Area

Company: 8-figure, private equity owned provider of consumer weight loss products & education services and manufacturer/contract manufacturer of protein-based food products and supplements.Lead development and execution of turnaround strategy for company in workout relationship with 8-bank lender syndicate. Manage 280-person organization, 7 directs. Report to Board of Directors. • Presented and gained approval for strategic plan, rebuilt syndicate relationships, and negotiated new debt agreement between Board and lenders. • Significantly reduced 6-year trend of annual revenue and EBITDA declines. • Freed cash to create and pilot digital consumer lead generation program (social & paid media, search, advertising, call center) for Ideal Protein clinics. Model proved ability to scale. • Faced new competition and consumer sentiment shift as semaglutide products were approved by the FDA for weight loss. • Collaborated with court-appointed monitor, EY, to restructure company, maximize value, and continue to generate positive EBITDA and cash flow while company was offered for sale.

Miami-Fort Lauderdale Area

Company: $87 million (2021) women’s health care and pharmaceutical company, (NASDAQ: TXMD).Led commercial strategy development and execution; built organization. Managed 200-person team, 6 directs, and 8-figure budget. Reported to the CEO and the President.• Transformed a prescription prenatal vitamin company into a pharmaceutical company that competed successfully in $1+ billion markets. • Developed and presented commercial strategy to Board, investors, lenders, and potential partners. Played key role in securing 9-figure term loan and preferred stock investors.• Differentiated innovative, branded products in crowded, generic-dominated markets. • Launched IMVEXXYTM, TXMD’s first pharmaceutical product, in 2018. Grew to $32 million, 37% of product revenue, in 2021.• Launched ANNOVERATM and BIJUVATM in 2019. Grew to $38 million, 47% of product revenue, and $11 million, 12% of product revenue, respectively in 2021. • Guided a continuous growth playbook focused on KPIs, market access, channel relationships, sales, patient engagement, analytics/AI, and technology/operations.

New York City Metropolitan Area

Company: $53 billion, Fortune 100 consumer health care and biopharmaceutical company.Recruited to lead R&D and marketing for newly formed $2+ billion global wellness organization (consumer packaged goods). Reported to President, Consumer Global.• Created and executed brand extension roadmap that closed projected revenue gaps.• Established monthly innovation forum and governance process for project approvals, tracking, and evaluations.• Reviewed R&D pipeline against new governance standards. Canceled 15% of projects.

New York City Metropolitan Area

Recommended creation of a new, $1+ billion Women’s Health franchise (primary products were Premarin and Duavee, treatments for hot flashes, VVA and osteoporosis). Full P&L accountability. Reported to Head, North American Primary Care Products Division. • Negotiated staff and operating budget to launch Duavee and gain a fresh entrée to doctors’ offices for Premarin, a product first introduced in 1942.• Slowed Premarin revenue decline from double digits to mid-single digits and grew Duavee to $30 million in first year. Delivered forecasted results.

New York City Metropolitan Area

New York City Metropolitan Area

Company: $1 billion, global wellness company and commercial weight management program.Challenged by CEO to develop and execute a refreshed weight loss program. Reported to Chief Scientific Officer.• Developed and defended an evidence-based business case to completely overhaul the company’s weight loss points system.• Created brand momentum that drove significant 2011 revenue growth.• Awarded a patent — US8382482B2, Processes and systems for achieving and assisting in improved nutrition based on food energy data and relative healthfulness data.

Mba, Marketing

Ba, Psychology